MarketPulse

hypercortisolism

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

Corcept Stock Tanks 50% After FDA Rejection, Class Action Lawsuit Filed

Corcept Therapeutics faces class action lawsuit for allegedly misrepresenting FDA trial data; stock collapsed 50% after regulatory rejection of relacorilant drug.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

CORT Plunges 50% After FDA Rejection; Securities Fraud Lawsuit Filed

Corcept Therapeutics faces class action lawsuit after FDA rejected relacorilant drug application, triggering 50% stock collapse and disclosure allegations.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Corcept Therapeutics Hit with Class Action Over FDA Drug Study Misrepresentations

Law firm files securities lawsuit against $CORT alleging false statements about FDA interactions regarding relacorilant drug approval prospects.
CORTsecurities fraudclass action lawsuit